Eagle Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,616,670
| Closed | -$16.3M | – | 607 |
|
|
2021
Q1 | $16.3M | Sell |
1,616,670
-878,434
| -35% | -$8.84M | 0.07% | 255 |
|
|
2020
Q4 | $57.6M | Sell |
2,495,104
-273,405
| -10% | -$6.31M | 0.33% | 106 |
|
|
2020
Q3 | $39M | Sell |
2,768,509
-11,855
| -0.4% | -$167K | 0.2% | 168 |
|
|
2020
Q2 | $43.2M | Sell |
2,780,364
-50,690
| -2% | -$788K | 0.25% | 147 |
|
|
2020
Q1 | $26.2M | Buy |
2,831,054
+87,854
| +3% | +$812K | 0.16% | 187 |
|
|
2019
Q4 | $26.7M | Sell |
2,743,200
-25,460
| -0.9% | -$248K | 0.13% | 215 |
|
|
2019
Q3 | $22.2M | Buy |
2,768,660
+51,260
| +2% | +$411K | 0.11% | 222 |
|
|
2019
Q2 | $33.9M | Buy |
2,717,400
+104,042
| +4% | +$1.3M | 0.17% | 200 |
|
|
2019
Q1 | $35.5M | Buy |
2,613,358
+69,804
| +3% | +$949K | 0.19% | 193 |
|
|
2018
Q4 | $24.4M | Buy |
2,543,554
+2,459
| +0.1% | +$23.6K | 0.15% | 209 |
|
|
2018
Q3 | $30.7M | Sell |
2,541,095
-3,580
| -0.1% | -$43.3K | 0.15% | 212 |
|
|
2018
Q2 | $39.7M | Sell |
2,544,675
-103,502
| -4% | -$1.62M | 0.21% | 176 |
|
|
2018
Q1 | $39.8M | Sell |
2,648,177
-13,334
| -0.5% | -$201K | 0.22% | 167 |
|
|
2017
Q4 | $38.6M | Sell |
2,661,511
-36,991
| -1% | -$536K | 0.21% | 174 |
|
|
2017
Q3 | $40.5M | Buy |
+2,698,502
| New | +$40.5M | 0.23% | 146 |
|